Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00265941 · FLOW

Participant flow

Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With Stage III or Stage IV Head and Neck Cancer · Source last updated 2022-06-14

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups
  1. description
    Radiation therapy (RT) as accelerated fractionation by concomitant boost (AFX-CB) or intensity-modulated radiation therapy (IMRT) plus cisplatin
    id
    FG000
    title
    RT + Cisplatin
  2. description
    Radiation therapy (RT) as accelerated fractionation by concomitant boost (AFX-CB) or intensity-modulated radiation therapy (IMRT) plus cisplatin plus cetuximab
    id
    FG001
    title
    RT + Cisplatin + Cetuximab
periods
  1. drop Withdraws
    1. reasons
      1. group Id
        FG000
        num Subjects
        22
      2. group Id
        FG001
        num Subjects
        25
      type
      Protocol Violation
    2. reasons
      1. group Id
        FG000
        num Subjects
        1
      2. group Id
        FG001
        num Subjects
        1
      type
      Lost to Follow-up
    milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        470
      2. group Id
        FG001
        num Subjects
        470
      type
      STARTED
    2. achievements
      1. comment
        Subjects with data available for the primary analysis are considered to have completed the study.
        group Id
        FG000
        num Subjects
        447
      2. comment
        Subjects with data available for the primary analysis are considered to have completed the study.
        group Id
        FG001
        num Subjects
        444
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        23
      2. group Id
        FG001
        num Subjects
        26
      type
      NOT COMPLETED
    title
    Overall Study
Complete source fields
groups
  1. description
    Radiation therapy (RT) as accelerated fractionation by concomitant boost (AFX-CB) or intensity-modulated radiation therapy (IMRT) plus cisplatin
    id
    FG000
    title
    RT + Cisplatin
  2. description
    Radiation therapy (RT) as accelerated fractionation by concomitant boost (AFX-CB) or intensity-modulated radiation therapy (IMRT) plus cisplatin plus cetuximab
    id
    FG001
    title
    RT + Cisplatin + Cetuximab
periods
  1. drop Withdraws
    1. reasons
      1. group Id
        FG000
        num Subjects
        22
      2. group Id
        FG001
        num Subjects
        25
      type
      Protocol Violation
    2. reasons
      1. group Id
        FG000
        num Subjects
        1
      2. group Id
        FG001
        num Subjects
        1
      type
      Lost to Follow-up
    milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        470
      2. group Id
        FG001
        num Subjects
        470
      type
      STARTED
    2. achievements
      1. comment
        Subjects with data available for the primary analysis are considered to have completed the study.
        group Id
        FG000
        num Subjects
        447
      2. comment
        Subjects with data available for the primary analysis are considered to have completed the study.
        group Id
        FG001
        num Subjects
        444
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        23
      2. group Id
        FG001
        num Subjects
        26
      type
      NOT COMPLETED
    title
    Overall Study

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice